Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

T-Cell Monitoring for the Recently Expanded Repertoire of HLA Class I-Restricted Minor Histocompatibility Antigens Using Barcoded Peptide-MHC Multimers

Kyra J. Fuchs, Marcus Göransson, Michel G.D. Kester, Natasja W. Ettienne, Marian van de Meent, Rob C.M. de Jong, Eva A.S. Koster, Constantijn J.M. Halkes, Ferenc A. Scheeren, Mirjam H.M. Heemskerk, Peter Van Balen, J.H. Frederik Falkenburg, Sine R. Hadrup, Marieke Griffioen

Blood (2024) 144 (Supplement 1): 691.

https://doi.org/10.1182/blood-2024-197955

Published: 2024

Journal Articles

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, Indu Khatri, Michel G. D. Kester, Eva A. S. Koster, Georgia Koutsoumpli, Arnoud H. de Ru, Cornelis A. M. van Bergen, Peter A. van Veelen, Peter A. C. ’t Hoen, Peter van Balen, Erik B. van den Akker, J. Hendrik Veelken, Constantijn J. M. Halkes, J. H. Frederik Falkenburg, Marieke Griffioen

Blood (2024) 143 (18): 1856–1872.

https://doi.org/10.1182/blood.2023022343

Published: 2024

Includes: Supplemental data

Journal Articles

Large Scale Identification and Validation of 85 New HLA Class I-Restricted Minor Histocompatibility Antigens for Immune Monitoring and Modulation after Allogeneic Stem Cell Transplantation

Kyra J. Fuchs, M. Willy Honders, Marian van de Meent, Indu Khatri, Eva A.S. Koster, Cornelis A.M. van Bergen, Erik B. van den Akker, Constantijn J.M. Halkes, J.H. Frederik Falkenburg, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 10196–10197.

https://doi.org/10.1182/blood-2022-157938

Published: 2022

Journal Articles

The Allo-HLA-DP Restricted T Cell Repertoire Contains a Variety of Tissue-Restricted Specificities with Therapeutic Value

Aicha Laghmouchi, Conny Hoogstraten, Peter Van Balen, MD, Rick van de Water, Marian van de Meent, J.H. Frederik Falkenburg, Prof, MD PhD, Inge Jedema, PhD

Blood (2016) 128 (22): 3356.

https://doi.org/10.1182/blood.V128.22.3356.3356

Published: 2016

Journal Articles

A Polyclonal Population of Piga Mutant CD52 and GPI Anchor Negative T Cells Can Give Early Immune Protection after Alemtuzumab-Based T Cell Depleted Allogeneic Stem Cell Transplantation

Floris C. Loeff, J.H. Frederik Falkenburg, MD PhD, Lois Hageman, Sabrina A.J. Veld, Marian van de Meent, Constantijn J.M. Halkes, MD PhD, Inge Jedema, PhD

Blood (2015) 126 (23): 3134.

https://doi.org/10.1182/blood.V126.23.3134.3134

Published: 2015

Journal Articles

Immune Surveillance By Autoreactive Helper But Not Cytolytic T Cells Is a Common Phenomenon In Patients With Acute Myeloid Leukemia

Tin Sing Lam, Marian van de Meent, J.H. Frederik Falkenburg, MD, PhD, Inge Jedema, PhD

Blood (2013) 122 (21): 1044.

https://doi.org/10.1182/blood.V122.21.1044.1044

Published: 2013

Journal Articles

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Sanja Stevanović, Cornelis A. M. van Bergen, Simone A. P. van Luxemburg-Heijs, Boris van der Zouwen, Ekaterina S. Jordanova, Alwine B. Kruisselbrink, Marian van de Meent, Jessica C. Harskamp, Frans H. J. Claas, Erik W. A. Marijt, Jaap Jan Zwaginga, Constantijn J. M. Halkes, Inge Jedema, Marieke Griffioen, J. H. Frederik Falkenburg

Blood (2013) 122 (11): 1963–1973.

https://doi.org/10.1182/blood-2012-12-470872

Published: 2013

Includes: Supplemental data

Journal Articles

High Avidity HLA-A2-Restricted CD8+ T Cells against the Wilms Tumor Protein (WT1) Can Be Isolated Only from HLA-A2 Negative Donors Not Subjected to HLA-A2-Mediated Thymic Deletion

Inge Jedema, PhD, Marian van de Meent, Willem J.J. Falkenburg, Michel G.D. Kester, Roel Willemze, J.H. Frederik Falkenburg

Blood (2008) 112 (11): 3895.

https://doi.org/10.1182/blood.V112.11.3895.3895

Published: 2008

Journal Articles

Both the Activation Kinetics and the Frequency of Regulatory T Cells Determine the Ability to Generate Primary Anti-Tumor and Pathogen- Specific Immune Responses from a Naïve Donor T Cell Repertoire

Inge Jedema, PhD, Jeanette Pots, Marian van de Meent, Roel Willemze, J.H. Frederik Falkenburg

Blood (2008) 112 (11): 3898.

https://doi.org/10.1182/blood.V112.11.3898.3898

Published: 2008

Journal Articles

Efficient Induction and Isolation of CMV-Specific CD8+ T Cells from CMV Seronegative Donors for the Treatment of CMV Reactivation in CMV Seropositive Patients Transplanted with a CMV Seronegative Donor.

Inge Jedema, Marian van de Meent, Pim L.J. van der Heiden, Erik W.A. Marijt, Pauline Meij, Roel Willemze, J.H. Frederik Falkenburg

Blood (2007) 110 (11): 1053.

https://doi.org/10.1182/blood.V110.11.1053.1053

Published: 2007

Journal Articles

Successful Generation of Mature Professional Acute Myeloid Leukemia (AML) – Antigen Presenting Cells (APC) Does Not Predict Successful Induction of AML Reactive T Cells for Adoptive Immunotherapy.

Pauline Meij, Marian van de Meent, Inge Jedema, Roel Willemze, J.H. Frederik Falkenburg

Blood (2005) 106 (11): 2789.

https://doi.org/10.1182/blood.V106.11.2789.2789

Published: 2005

NARROW

T-Cell Monitoring for the Recently Expanded Repertoire of HLA Class I-Restricted Minor Histocompatibility Antigens Using Barcoded Peptide-MHC Multimers

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens

Large Scale Identification and Validation of 85 New HLA Class I-Restricted Minor Histocompatibility Antigens for Immune Monitoring and Modulation after Allogeneic Stem Cell Transplantation

The Allo-HLA-DP Restricted T Cell Repertoire Contains a Variety of Tissue-Restricted Specificities with Therapeutic Value

A Polyclonal Population of Piga Mutant CD52 and GPI Anchor Negative T Cells Can Give Early Immune Protection after Alemtuzumab-Based T Cell Depleted Allogeneic Stem Cell Transplantation

Immune Surveillance By Autoreactive Helper But Not Cytolytic T Cells Is a Common Phenomenon In Patients With Acute Myeloid Leukemia

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

High Avidity HLA-A2-Restricted CD8+ T Cells against the Wilms Tumor Protein (WT1) Can Be Isolated Only from HLA-A2 Negative Donors Not Subjected to HLA-A2-Mediated Thymic Deletion

Both the Activation Kinetics and the Frequency of Regulatory T Cells Determine the Ability to Generate Primary Anti-Tumor and Pathogen- Specific Immune Responses from a Naïve Donor T Cell Repertoire

Efficient Induction and Isolation of CMV-Specific CD8+ T Cells from CMV Seronegative Donors for the Treatment of CMV Reactivation in CMV Seropositive Patients Transplanted with a CMV Seronegative Donor.

Successful Generation of Mature Professional Acute Myeloid Leukemia (AML) – Antigen Presenting Cells (APC) Does Not Predict Successful Induction of AML Reactive T Cells for Adoptive Immunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only